Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
European Journal of Cancer Care
|
September 5, 2018
Self-reported quality of life and hope in phase-I trial participants: An observational prospective cohort study
Diane A van der Biessen, Wendy H Oldenmenger, Peer G van der Helm, et al.
The Pharmacogenomics Journal
|
January 27, 2016
Sunitinib-induced hypertension in CYP3A4 rs4646437 A-allele carriers with metastatic renal cell carcinoma
M H Diekstra, A Belaustegui, J J Swen, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 2011
Effect of ABCC2 (MRP2) transport function on erythromycin metabolism
R M Franke, C S Lancaster, C J Peer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Pharmacokinetic, metabolic, and pharmacodynamic profiles in a dose-escalating study of irinotecan and cisplatin
M J de Jonge, J Verweij, P de Bruijn, et al.
Clinical Pharmacology and Therapeutics
|
June 21, 2018
Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil Therapy
Jan H Beumer, Edward Chu, Carmen Allegra, et al.
Lung
|
December 2, 2024
Holter Monitoring and Cardiac Biomarkers in Screening for Cardiac Sarcoidosis
A L M Bakker, H Mathijssen, M P Huitema, et al.
EJNMMI Research
|
December 20, 2021
The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis
H Mathijssen, T W H Tjoeng, R G M Keijsers, et al.
The Oncologist
|
October 9, 2010
Effects of mannose-binding lectin polymorphisms on irinotecan-induced febrile neutropenia
Jessica M van der Bol, Floris A de Jong, Ron H van Schaik, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 3, 2017
Sorafenib-Induced Changes in Thyroid Hormone Levels in Patients Treated for Hepatocellular Carcinoma
Carolien M Beukhof, Leni van Doorn, Theo J Visser, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 11, 2026
Long-term survivors of melanoma after anti-PD-1 therapy demonstrate on-treatment increase in abundance of 4-1BB+ CD4 T cells in blood
Karlijn de Joode, Hayri E Balcioglu, Mandy van Brakel, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
European Journal of Cancer Care
|
September 5, 2018
Self-reported quality of life and hope in phase-I trial participants: An observational prospective cohort study
Diane A van der Biessen, Wendy H Oldenmenger, Peer G van der Helm, et al.
The Pharmacogenomics Journal
|
January 27, 2016
Sunitinib-induced hypertension in CYP3A4 rs4646437 A-allele carriers with metastatic renal cell carcinoma
M H Diekstra, A Belaustegui, J J Swen, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 2011
Effect of ABCC2 (MRP2) transport function on erythromycin metabolism
R M Franke, C S Lancaster, C J Peer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Pharmacokinetic, metabolic, and pharmacodynamic profiles in a dose-escalating study of irinotecan and cisplatin
M J de Jonge, J Verweij, P de Bruijn, et al.
Clinical Pharmacology and Therapeutics
|
June 21, 2018
Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil Therapy
Jan H Beumer, Edward Chu, Carmen Allegra, et al.
Lung
|
December 2, 2024
Holter Monitoring and Cardiac Biomarkers in Screening for Cardiac Sarcoidosis
A L M Bakker, H Mathijssen, M P Huitema, et al.
EJNMMI Research
|
December 20, 2021
The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis
H Mathijssen, T W H Tjoeng, R G M Keijsers, et al.
The Oncologist
|
October 9, 2010
Effects of mannose-binding lectin polymorphisms on irinotecan-induced febrile neutropenia
Jessica M van der Bol, Floris A de Jong, Ron H van Schaik, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 3, 2017
Sorafenib-Induced Changes in Thyroid Hormone Levels in Patients Treated for Hepatocellular Carcinoma
Carolien M Beukhof, Leni van Doorn, Theo J Visser, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 11, 2026
Long-term survivors of melanoma after anti-PD-1 therapy demonstrate on-treatment increase in abundance of 4-1BB+ CD4 T cells in blood
Karlijn de Joode, Hayri E Balcioglu, Mandy van Brakel, et al.
Page
of 4